The definition and classification of cardiomyopathy have evolved considerably in recent
years. Cardiomyopathy can be separated into primary (genetic, mixed, or acquired) and …

This guideline describes the approach and expertise needed for the genetic evaluation of
cardiomyopathy. First published in 2009 by the Heart Failure Society of America (HFSA), the …

Purpose The purpose of this document is to provide updated guidance for the genetic
evaluation of cardiomyopathy and for an approach to manage secondary findings from …

Advances in molecular genetics present new opportunities and challenges for cardiologists
who manage patients and families with cardiomyopathies. The aims of this position …

Background: Childhood cardiomyopathies are progressive and often lethal disorders,
forming the most common cause of heart failure in children. Despite severe outcomes, their …

Cardiomyopathy is an anatomic and pathologic diagnosis associated with muscle or
electrical dysfunction of the heart. Cardiomyopathies represent a heterogeneous group of …

Inherited cardiomyopathies include hypertrophic cardiomyopathy, dilated cardiomyopathy,
arrhythmogenic right ventricular cardiomyopathy, left ventricular noncompaction, and …

Background Cardiomyopathy (CM) remains one of the leading cardiac causes of death in
children, although in the majority of cases, the cause is unknown. To have an impact on …

Cardiomyopathies (ie, diseases of the heart muscle) are major causes of morbidity and
mortality. A significant percentage of patients with cardiomyopathies have genetic-based …

Cardiomyopathies are defined as diseases of the myocardium, which cause cardiac
dysfunction with heart failure, arrhythmia, and sudden death. Cardiomyopathies represent a …